Reports Q4 revenue $98.13M, consensus $94.61M. "I am proud of the significant progress our team made this year. We achieved strong annual sales growth, launched Hydrafacial Syndeo, our innovative next generation delivery system, and continued to build the world’s premiere skincare booster portfolio," said BeautyHealth president and CEO Andrew Stanleick. "We enter 2023 from a position of strength, having invested to expand our global capabilities and scale. As planned, we are now turning our focus to driving profitable growth and flawlessly executing our international Syndeo launch in the second quarter."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SKIN:
